HEC-1-A Cells

HEC-1-A cells are a well-characterized human endometrial adenocarcinoma cell line derived from the malignant tissue of a 71-year-old Caucasian woman. This cell line, established in the mid-1970s, is extensively used in gynecological cancer research, particularly for studying endometrial carcinoma. Morphologically, HEC-1-A cells are epithelial-like and form a monolayer of polygonal cells when cultured. They exhibit a robust and adherent growth pattern, which is typical of epithelial cells originating from solid tumors. The morphological characteristics of HEC-1-A cells make them a valuable model for studying cellular behaviors that are central to cancer progression, such as adhesion, migration, and invasion. Genotypically, HEC-1-A cells harbor several genetic aberrations that are relevant to cancer biology, including mutations in key regulatory genes like p53 and PTEN, both of which are commonly mutated in endometrial cancer. These genetic features contribute to the cells' utility in researching the molecular underpinnings of endometrial carcinogenesis and the cellular pathways leading to tumor growth and resistance to therapy. Research using HEC-1-A cells has significantly advanced our understanding of endometrial cancer, particularly in terms of hormonal influences, genetic mutations, and responses to chemotherapeutic agents. As a result, this cell line continues to be instrumental in developing more effective diagnostic and therapeutic strategies for endometrial carcinoma.